Zusammenfassung
Akute Leukämien sind maligne Erkrankungen hämatopoetischer Stammzellen, die bei erhaltener Teilungsfähigkeit mit einem teilweisen oder völligem Verlust der Fähigkeit zur Ausdifferenzierung zu reifen Funktionszellen verbunden sind. Je nach betroffener hämatopoetischer Zellreihe wird zwischen den beiden Hauptformen der akuten lymphatischen und der akuten myeloischen Leukämie unterschieden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bennett JM, Catovsky D, Daniel MT et al. (1985) Proposed revised criteria of the classification of acute myeloid leukemia. Ann Intern Med 103: 626–629
Bishop JF, Matthews JP, Graham AY et al. (1996) A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood 87: 1710–1717
Büchner T (1996) Akute myeloische Leukämie. Internist 37: 1008–1012
Büchner T, Hiddemann W, Wörmann B et al. (1998) Intensified therapy of AML–the role of the HAM combination. In: Hiddemann W, Büchner T, Wörmann B, Ritter J, Creutzig U, Keating M, Plunkett W (eds) Acute Leukemias VII: Experimental Approaches and Novel Therapies: Springer-Verlag 821–824
Büchner T, Hiddemann W, Koenigsmann M et al. (1991) Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse. Blood 78: 1190–1197
Büchner T, Urbanitz D, Hiddemann W et al. (1985) Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): Two multicenter studies of the German AML Cooperative Group. J Clin Oncol 3: 1583–1589
Camitta B. Mahoney D, Leventhal B et al. (1994) Intensive intravenous methotrexate and mercaptopurine treatment of higher risk non-T, non-B acute lymphocytic leukemia. A Pedriatric Oncology Group Study. J Clin Oncol 12: 1383–1389
Cassileth PA, Lynch E, Hines JD et al. (1992) Varying intensity of postremission therapy in acute myeloid leukemia. Blood 79: 1924–1930
Cheson BD, Cassileth PA, Head DR et al. (1990) Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and responses on acute myeloid leukemia. J Clin Oncol 8: 813–819
Clarkson B, Gaynor J, Little C et al. (1990) Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemia. Hematol Blood Transfus 33: 397–408
Cline MJ (1994) The molecular basis of leukemia. N Engl J Med 330: 328–336
Degos L (1994) Is acute promyelocytic leukemia a curable disease? Treatment strategy for a long-term survival. Leukemia 8: 9111–9113
Dekker AW, van’t Veer MB, Haak HL et al. (1994) Conventional remisson induction followed by intensive consolidation without maintenance therapy in adult acute lymphoblastic leukemia. Results from a phase II clinical trial in 130 patients. Blood 84, Suppl 1: 144a
Dicke KA, Hoelzer D, Gorin NC et al. (1993) The role of bone marrow transplantation in adult acute lymphocytic leukemia. Ann Oncol 4: 581–590
European Group for the Immunological Characterization of Leukemias (EGIL); Bene MC, Castoldi G, Knapp W et al. (1995) Proposals for the immunological classification of acute leukemias. Leukemia 9:1783–1786
Fiere D, Lepage E, Sebban C et al. (1993) Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. J Clin Oncol 11: 1990–2001
Gale RP, Büchner T Horowitz MM, Zhang MJ (1993) Chemotherapy versus bone marrow transplantation for adults with acute myelogenous leukemia (AML) in first remission. Blood 82; Suppl:168 a
Hoelzer D (1993) Acute lymphoblastic leukemia–progress in children, less in adults. N Engl J Med 329: 1343–1345
Hoelzer D (1994) Treatment of acute lymphoblastic leukemia. Sem Hemtol 31: 1–15
Hoelzer D, Ludwig WD, Thiel E et al. (1996) Improved outcome in adult-B-cell acute lymphoblastic leukemia. Blood 87: 495–452
Larson RA, Dodge RK, Burns CP et al. (1995) A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811. Blood 5: 2025–2037
Mandelli F, Annino L, Vegna ML et al. (1996) Adult acute lymphoblastic leukemia (ALL): Results of the Gimema ALL 0288 trial. Br J Hematol 93: 144–152
Mayer RJ, Davis RB, Schiffer CA et al. (1994) Intensive post-remission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331: 896–942
Ohno R, Tomonaga M, Kobayashi T et al. (1990) Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N Engl J Med 323: 871–877
Ottmann OG, Hoelzer D, Gracien E et al. (1995) Concomittant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomised phase II trial. Blood 86: 444–454
Rowe JM, Andersen J, Mazza JJ et al. (1993) Phase III randomized placebo-controlled study of granulocyte-macrophage-colony stimulating factor (GM-CSF) in adult patients (55–7o years) with acute myelogenous leukemia (AML). A study of the Eastern Cooperative Oncology Group (ECOG). Blood 82; Suppl 1:329 a
Swansbury GJ, Lawler SD, Alimena G et al. (1994) Longterm survival in acute myelogenous leukemia: A second follow-up of the Fourth International Workshop on chromosomes in leukemia. Cancer Genet Cytogenet 73: 1–7
von Schilling C, Duyster J, Herrmann F (1996) Fortschritte im Verständnis der Leukämieentstehung. Internist 37: 971–981
Warrell RP, Frankel SR, Miller WH et al. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324: 1385–1393
Zittoun RA, Mandelli F,Willemze R et al. (1995) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 332: 217–223
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hiddemann, W. (1999). Akute Leukämien. In: Paumgartner, G., et al. Therapie innerer Krankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10477-4_62
Download citation
DOI: https://doi.org/10.1007/978-3-662-10477-4_62
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-10478-1
Online ISBN: 978-3-662-10477-4
eBook Packages: Springer Book Archive